Auriculotherapy in the Treatment of Dysmenorrhea

Sponsor
University of Sorocaba (Other)
Overall Status
Completed
CT.gov ID
NCT03148223
Collaborator
(none)
74
1
2
17
4.3

Study Details

Study Description

Brief Summary

This study aims to determine if auriculotherapy is effective in the treatment of dysmenorrhoea. This intervention consists of fixation of yellow mustard seeds at specific points of the auricular pavilion (or area), with opaque tape. Half of the participants will have specific ear pinch points stimulated by mustard seeds fixed with opaque plaster, while the other half will have only the adhesive plasters fixed, without the seeds for stimulation.

Condition or Disease Intervention/Treatment Phase
  • Device: auriculotherapy
N/A

Detailed Description

Primary dysmenorrhoea is responsible for the most part of dissatisfactions in the female class, in the face of discomforts which are caused monthly. For this, the income index of this woman in the work environment tends to reduce, thus harming the development of every sector to which she responds. The expected effects, after the intervention, will be positive, favoring a considerable improvement of the symptoms reported by the women. We chose auriculotherapy because it is a non-medicated, noninvasive intervention that is inexpensive.

Study Design

Study Type:
Interventional
Actual Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Participants will not be informed which group they belong to, intervention or control. Who will apply the treatment will not be blind, since during the treatment it will know if the points to be stimulated must contain seeds of mustard or just plaster, but will not have previous knowledge of the members of the groups. The evaluator, who is responsible for applying the pre- and post-treatment evaluation instruments, will be blind and not aware of the research intervention. The data analyst will also be early for the intervention group.
Primary Purpose:
Treatment
Official Title:
Effect of Auriculotherapy in the Treatment of Dysmenorrhea: Protocol of a Randomized Controlled Clinical Trial
Actual Study Start Date :
May 15, 2017
Actual Primary Completion Date :
Aug 30, 2018
Actual Study Completion Date :
Oct 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Auriculotherapy with application of mustard seeds fixed with adhesive tape at specific points in the auricle during one session per week lasting 20 minutes for 3 consecutive months.

Device: auriculotherapy
The participants will be submitted to a session per week with duration of 20 minutes, for three consecutive months, to fix the adhesives. The points selected for stimulation, according to Chinese atrial mapping, are: uterus, endocrine, ovary, pituitary, shen men, sympathetic, and liver. Participants will be advised to remain with the stickers fixed to the auricle for six days.
Other Names:
  • acupuncture
  • Placebo Comparator: Control

    Auriculotherapy with tape-only fixation in the auricle, without mustard seeds, following the same stitch protocol used with the intervention group, during a session per week lasting 20 minutes, for three consecutive months.

    Device: auriculotherapy
    The participants will be submitted to a session per week with duration of 20 minutes, for three consecutive months, to fix the adhesives. The points selected for stimulation, according to Chinese atrial mapping, are: uterus, endocrine, ovary, pituitary, shen men, sympathetic, and liver. Participants will be advised to remain with the stickers fixed to the auricle for six days.
    Other Names:
  • acupuncture
  • Outcome Measures

    Primary Outcome Measures

    1. Measurement on pain perception [12 weeks]

      The numerical visual scale of pain 0-10 (0 = no pain, 10 = worst possible pain), applied at the beginning of the intervention period and reapplied to each menstrual period during the 12 weeks of follow-up will be used.

    Secondary Outcome Measures

    1. Welfare [12 weeks]

      The quality of life questionnaire (Short-Form Health Survey SF36) will be applied at the beginning of the intervention period and reapplied at the end of the 12 weeks of intervention.

    2. Number of participants with adverse events [12 weeks]

      Adverse events will be collected spontaneously by the active survey, at all visits of participants.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • To be eligible to participate in this study, the individual must meet the following criteria:

    • Free and informed consent form, duly signed and dated

    • Consent to voluntarily participate in all study procedures and availability for the duration of the study

    • Female subjects

    • Age above of 18 years old

    • Enjoy good general health

    • Have active menstrual cycle

    • Complaint about dysmenorrhea

    Exclusion Criteria:
    • An individual who meets any of the following criteria will be excluded from participation in this study:

    • Clinical diagnosis of endometriosis

    • Myomas

    • Pelvic inflammatory disease

    • Adenomyosis

    • In the active phase for treatment of cancer (chemotherapy or radiotherapy)

    • Women who are already in menopause

    • Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Universidade de Sorocaba - Campus Cidade Universitária Sorocaba São Paulo Brazil 18023-000

    Sponsors and Collaborators

    • University of Sorocaba

    Investigators

    • Principal Investigator: Luciane Cruz Lopes, Universidade de Sorocaba

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Luciane Cruz Lopes, Responsible researcher, University of Sorocaba
    ClinicalTrials.gov Identifier:
    NCT03148223
    Other Study ID Numbers:
    • 45269015.3.0000.5500
    First Posted:
    May 10, 2017
    Last Update Posted:
    Oct 23, 2018
    Last Verified:
    Oct 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Luciane Cruz Lopes, Responsible researcher, University of Sorocaba
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 23, 2018